MS
NVOS

Maven Securities’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Maven Securities’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-834
Closed -$29K – 1416
2021
Q1 		$29K Buy
+834
New +$34.8K ﹤0.01% 1128

Other funds holding NVOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Maven Securities's NVOS Position: Q2 2021 in Review

Maven Securities sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q2 2021, closing a stake of 834 shares — an estimated $29K sold.

Maven Securities first reported a position in NVOS in Q1 2021 and held it in 1 quarter. The position peaked at $29K in Q1 2021. 10 funds tracked by Wall St. Rank hold NVOS as of Q2 2021.

  • Maven Securities reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Maven Securities sold 834 Novo Integrated Sciences, Inc. Common Stock shares in Q2 2021, an estimated $29K.
  • Maven Securities first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Maven Securities's Novo Integrated Sciences, Inc. Common Stock position peaked at $29K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.